ArticleVaccines2024

Enhanced Broad-Spectrum Efficacy of an L2-Based mRNA Vaccine Targeting HPV Types 6, 11, 16, 18, with Cross-Protection Against Multiple Additional High-Risk Types.

Kosuke Tsukamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.